NCT02553330View on ClinicalTrials.gov

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

PHASE2TerminatedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

November 18, 2015

Primary Completion Date

October 3, 2017

Study Completion Date

October 3, 2017

Conditions

Alopecia Areata

Interventions

DRUG

Placebo Cream

DRUG

Ruxolitinib Phosphate Cream

Trial Locations (18)

Unknown

Birmingham

Hot Springs

New Haven

Trumbull

Miami

Beverly

Boston

Clinton Township

Fort Gratiot

Fridley

Minneapolis

Winston-Salem

Cleveland

Portland

Austin

Houston

Katy

Norfolk

Sponsors

Lead Sponsor

Incyte Corporation

All Listed Sponsors

lead

Incyte Corporation

INDUSTRY

NCT02553330 - A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) | Biotech Hunter | Biotech Hunter